Conservative management of morbidly adherent placenta: Expert review

American Journal of Obstetrics and Gynecology

Volumn 213, Issue 6, 2015, Pages 755-760

  Fox, Karin A ^a   Shamshirsaz, Alireza A ^a   Carusi, Daniela ^b   Secord, Angeles Alvarez ^c   Lee, Paula ^c   Turan, Ozhan M ^d   Huls, Christopher ^e   Abuhamad, Alfred ^f   Simhan, Hyagriv ^g   Barton, John ^h   Wright, Jason ^j   Silver, Robert ⁱ   Belfort, Michael A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h Baptist Health Lexington   (United States)

ⁱ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^j Columbia University College of Physicians and Surgeons ^*  (United States)

more..

Author keywords

accreta; conservative management; increta; percreta

Indexed keywords

METHOTREXATE; ENZYME INHIBITOR;

ARTERY OCCLUSION; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; INCIDENCE; LIVE BIRTH; LONG TERM CARE; MATERNAL MORTALITY; MORBIDLY ADHERENT PLACENTA; PLACENTA ACCRETA; PLACENTA DISORDER; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; TERTIARY CARE CENTER; UNITED KINGDOM; BALLOON OCCLUSION; BLOOD LOSS, SURGICAL; LIGATION; MYOMETRIUM; PLACENTA, RETAINED; POSTOPERATIVE HEMORRHAGE; POSTPARTUM HEMORRHAGE; PREGNANCY; SURGERY; TIME TO TREATMENT; UTERINE ARTERY; UTERINE ARTERY EMBOLIZATION;

BALLOON OCCLUSION; BLOOD LOSS, SURGICAL; ENZYME INHIBITORS; FEMALE; HUMANS; HYSTERECTOMY; HYSTEROSCOPY; LIGATION; METHOTREXATE; MYOMETRIUM; ORGAN SPARING TREATMENTS; PLACENTA ACCRETA; PLACENTA, RETAINED; POSTOPERATIVE HEMORRHAGE; POSTPARTUM HEMORRHAGE; PREGNANCY; PRENATAL DIAGNOSIS; TIME-TO-TREATMENT; UTERINE ARTERY; UTERINE ARTERY EMBOLIZATION;

EID: 84930267788     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.04.034     Document Type: Review

References (61)

1. K.S. Khan, D. Wojdyla, L. Say, A.M. Gulmezoglu, and P.F. Van Look WHO analysis of causes of maternal death: a systematic review Lancet 367 2006 1066 1074
2. D.B. Hart Case of successful caesarean section (Porro's modification) Br Med J 1 1889 183 184
3. R.P. McKeogh, and E. D'Errico Placenta accreta: clinical manifestations and conservative management N Engl J Med 245 1951 159 165
4. Publications Committee for Society for Maternal-Fetal Medicine M.A. Belfort Placenta accreta Am J Obstet Gynecol 203 2010 430 439
5. K.E. Fitzpatrick, S. Sellers, P. Spark, J.J. Kurinczuk, P. Brocklehurst, and M. Knight Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study PLoS One 7 2012 e52893
6. G. Kayem, C. Davy, F. Goffinet, C. Thomas, D. Clement, and D. Cabrol Conservative versus extirpative management in cases of placenta accreta Obstet Gynecol 104 2004 531 536
7. H. Brody Placenta accreta: report of five cases and a plan of management Can Med Assoc J 89 1963 499 503
8. O.C. Ezechi, B.K. Kalu, F.O. Njokanma, C.A. Nwokoro, and G.C. Okeke Emergency peripartum hysterectomy in a Nigerian hospital: a 20-year review J Obstet Gynaecol 24 2004 372 373
9. L.O. Ajah, M.I. Eze, C.C. Dim, and et al. Placenta percreta in a booked multiparous woman with minimal risk factors and challenges of management in a low resource setting Niger J Med 21 2012 359 360
10. M. Tikkanen, J. Paavonen, M. Loukovaara, and V. Stefanovic Antenatal diagnosis of placenta accreta leads to reduced blood loss Acta Obstet Gynecol Scand 90 2011 1140 1146
11. C.R. Warshak, G.A. Ramos, R. Eskander, and et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta Obstet Gynecol 115 2010 65 69
12. K.E. Fitzpatrick, S. Sellers, P. Spark, J.J. Kurinczuk, P. Brocklehurst, and M. Knight The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study BJOG 121 2014 62 70 discussion 70-1
13. A.A. Shamshirsaz, B. Salmanian, K.A. Fox, and et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach Am J Obstet Gynecol 212 2015 218.e1 218.e9
14. A.G. Eller, M.A. Bennett, M. Sharshiner, and et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care Obstet Gynecol 117 2 Pt 1 2011 331 337
15. A. Perez-Delboy, and J.D. Wright Surgical management of placenta accreta: to leave or remove the placenta? BJOG 121 2014 163 169 discussion 169-70
16. Y. Aboulafia, O. Lavie, S. Granovsky-Grisaru, O. Shen, and Y.Z. Diamant Conservative surgical management of acute abdomen caused by placenta percreta in the second trimester Am J Obstet Gynecol 170 5 Pt 1 1994 1388 1389
17. L.C. Lee, H.H. Lin, C.W. Wang, W.F. Cheng, and S.C. Huang Successful conservative management of placenta percreta with rectal involvement in a primigravida Acta Obstet Gynecol Scand 74 1995 839 841
18. P.S. Lee, R. Bakelaar, C.B. Fitpatrick, S.C. Ellestad, L.J. Havrilesky, and A. Alvarez Secord Medical and surgical treatment of placenta percreta to optimize bladder preservation Obstet Gynecol 112 2 Pt 2 2008 421 424
19. E. Chandraharan, S. Rao, A.M. Belli, and S. Arulkumaran The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta Int J Gynaecol Obstet 117 2012 191 194
20. J.M. Palacios Jaraquemada, M. Pesaresi, J.C. Nassif, and S. Hermosid Anterior placenta percreta: surgical approach, hemostasis and uterine repair Acta Obstet Gynecol Scand 83 2004 738 744
21. M. Jeremiah Fecundity, barrenness and the importance of motherhood in two Nigerian plays Int J Humanit Soc Sci 4 2014 213 221
22. L. Sentilhes, F. Goffinet, and G. Kayem Management of placenta accreta Acta Obstet Gynecol Scand 92 2013 1125 1134
23. S. Pather, S. Strockyj, A. Richards, N. Campbell, B. de Vries, and R. Ogle Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature Austr N Z J Obstet Gynaecol 54 2014 84 87
24. L. Sentilhes, C. Ambroselli, G. Kayem, and et al. Maternal outcome after conservative treatment of placenta accreta Obstet Gynecol 115 2010 526 534
25. G. Legendre, F.J. Zoulovits, J. Kinn, L. Senthiles, and H. Fernandez Conservative management of placenta accreta: hysteroscopic resection of retained tissues J Minim Invas Gynecol 21 2014 910 913
26. C. Clausen, L. Lonn, and J. Langhoff-Roos Management of placenta percreta: a review of published cases Acta Obstet Gynecol Scand 93 2014 138 143
27. T.K. Lo, W.K. Yung, W.L. Lau, B. Law, S. Lau, and W.C. Leung Planned conservative management of placenta accreta - experience of a regional general hospital J Matern Fetal Neonatal Med 27 2014 291 296
28. S. Ferrazzani, L. Guariglia, S. Triunfo, L. Caforio, and A. Caruso Conservative management of placenta previa-accreta by prophylactic uterine arteries ligation and uterine tamponade Fetal Diagn Ther 25 2009 400 403
29. M. Albayrak, I. Ozdemir, O. Koc, and Y. Demiraran Post-partum haemorrhage from the lower uterine segment secondary to placenta praevia/accreta: successful conservative management with Foley balloon tamponade Austr N Z J Obstet Gynaecol 51 2011 377 380
30. N. Vrachnis, C. Iavazzo, N. Salakos, E. Papamargaritis, I. Boutas, and G. Creatsas Uterine tamponade balloon for the management of massive hemorrhage during cesarean section due to placenta previa/increta Clin Exp Obstet Gynecol 39 2012 255 257
31. A. Roulot, E. Barranger, O. Morel, P. Soyer, and D. Hequet [Two- and three-dimensional power Doppler ultrasound in the follow-up of placenta accreta treated conservatively] J Gynecol Obstet Biol Reprod 44 2015 176 183
32. F. Bretelle, B. Courbiere, C. Mazouni, and et al. Management of placenta accreta: morbidity and outcome Eur J Obstet Gynecol Reprod Biol 133 2007 34 39
33. M. Alanis, B.S. Hurst, P.B. Marshburn, and M.L. Matthews Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies Fertil Steril 86 2006 1514.e3 1514.e7
34. T.H. Kim, H.H. Lee, and J.J. Kwak Conservative management of abnormally invasive placenta: choriocarcinoma with uterine arteriovenous fistula from remnant invasive placenta Acta Obstet Gynecol Scand 92 2013 989 990
35. D. Hequet, O. Morel, P. Soyer, E. Gayat, C. Malartic, and E. Barranger Delayed hysteroscopic resection of retained tissues and uterine conservation after conservative treatment for placenta accreta Austr N Z J Obstet Gynaecol 53 2013 580 583
36. D.T. Rein, T. Schmidt, A.P. Hess, A. Volkmer, T. Schondorf, and M. Breidenbach Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage J Minim Invas Gynecol 18 2011 774 778
37. D. Hequet, A. Ricbourg, D. Sebbag, M. Rossignol, S. Lubrano, and E. Barranger [Placenta accreta: screening, management and complications] Gynecol Obstet Fertil 41 2013 31 37
38. Teixidor Viñas M, Belli A, Arulkumaran S, Chandraharan E. Prevention of postpartum haemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the Triple-P procedure. Ultrasound Obstet Gynecol 2014 [Epub ahead of print].
39. E. Chandraharan Should the Triple-P procedure be used as an alternative to peripartum hysterectomy in the surgical treatment of placenta percreta? Womens Health 8 2012 351 353
40. M. Teixidor Viñas, E. Chandraharan, M.V. Moneta, and A.M. Belli The role of interventional radiology in reducing haemorrhage and hysterectomy following caesarean section for morbidly adherent placenta Clin Radiol 69 2014 e345 e351
41. C. Clausen, J. Stensballe, C.K. Albrechtsen, M.A. Hansen, L. Lönn, and J. Langhoff-Roos Balloon occlusion of the internal iliac arteries in the multidisciplinary management of placenta percreta Acta Obstet Gynecol Scand 92 2013 386 391
42. E. Sivan, M. Spira, R. Achiron, and et al. Prophylactic pelvic artery catheterization and embolization in women with placenta accreta: can it prevent cesarean hysterectomy? Am J Perinatol 27 2010 455 461
43. O. Poujade, P.F. Ceccaldi, C. Davitian, and et al. Uterine necrosis following pelvic arterial embolization for post-partum hemorrhage: review of the literature Eur J Obstet Gynecol Reprod Biol 170 2013 309 314
44. M.S. Maassen, M.D. Lambers, R.P. Tutein Nolthenius, P.H. van der Valk, and O.E. Elgersma Complications and failure of uterine artery embolisation for intractable postpartum haemorrhage BJOG 116 2009 55 61
45. A. Al-Thunyan, O. Al-Meshal, H. Al-Hussainan, M.H. Al-Qahtani, A.A. El-Sayed, and M.M. Al-Qattan Buttock necrosis and paraplegia after bilateral internal iliac artery embolization for postpartum hemorrhage Obstet Gynecol 120 2 Pt 2 2012 468 470
46. S. Arulkumaran, C.S. Ng, I. Ingemarsson, and S.S. Ratnam Medical treatment of placenta accreta with methotrexate Acta Obstet Gynecol Scand 65 1986 285 286
47. T. Cirpan, C.Y. Sanhal, S. Yucebilgin, and S. Ozsener Conservative management of placenta previa percreta by leaving placental tissue in situ with arterial ligation and adjuvant methotrexate therapy J Turk Ger Gynecol Assoc 12 2011 127 129
48. N. Heiskanen, J. Kroger, S. Kainulainen, and S. Heinonen Placenta percreta: methotrexate treatment and MRI findings Am J Perinatol 25 2008 91 92
49. S. Lalchandani, M. Geary, C. O'Herlihy, and O. Sheil Conservative management of placenta accreta and unruptured interstitial cornual pregnancy using methotrexate Eur J Obstet Gynecol Reprod Biol 107 2003 96 97
50. G.M. Mussalli, J. Shah, D.J. Berck, A. Elimian, N. Tejani, and F.A. Manning Placenta accreta and methotrexate therapy: three case reports J Perinatol 20 2000 331 334
51. S. Pinho, S. Sarzedas, S. Pedroso, and et al. Partial placenta increta and methotrexate therapy: three case reports Clin Exp Obstet Gynecol 35 2008 221 224
52. A. Ramoni, E.M. Strobl, J. Tiechl, M. Ritter, and C. Marth Conservative management of abnormally invasive placenta: four case reports Acta Obstet Gynecol Scand 92 2013 468 471
53. S.K. Doumouchtsis, and S. Arulkumaran The morbidly adherent placenta: an overview of management options Acta Obstet Gynecol Scand 89 2010 1126 1133
54. S. Timmermans, A.C. van Hof, and J.J. Duvekot Conservative management of abnormally invasive placentation Obstet Gynecol Surv 62 2007 529 539
55. G.G. Briggs, R.K. Freeman, and S.J. Yaffe Methotrexate S. Seigafuse, R. Shaw, Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, 8th ed 2008 Lippincott, Williams & Wilkins Philadelphia, PA
56. J.F. Lindau, S. Mastroeni, A. Gaddini, and et al. Determinants of exclusive breastfeeding cessation: identifying an at risk population for special support Eur J Pediatr 174 2015 533 540
57. L. Sentilhes, G. Kayem, C. Ambroselli, and et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta Hum Reprod 25 2010 2803 2810
58. N.A. Deshpande, and D.A. Carusi Uterine rupture after prior conservative management of placenta accreta Obstet Gynecol 122 2 Pt 2 2013 475 478
59. M. Nisolle, K. Delbecque, S. Perrier D'Hauterive, A. Firquet, and F. Chantraine Hysteroscopic resection of abnormally invasive placenta residuals Acta Obstet Gynecol Scand 92 2013 451 456
60. European Working Group on Abnormally Invasive Placenta. Available at: ew-aip.org. Accessed Jan. 15, 2015.
61. G. Kayem, C. Deneux-Tharaux, L. Sentilhes PACCRETA Group PACCRETA: clinical situations at high risk of placenta ACCRETA/percreta: impact of diagnostic methods and management on maternal morbidity Acta Obstet Gynecol Scand 92 2013 476 482